Home / Going-concern warnings / Cue Biopharma, Inc.
Filed 2026-03-16 路 Form 10-K 路 Accession 0001193125-26-108287 nano
Price before filing: $8.51 (2026-03-13 close, split/dividend-adjusted)
Market cap at flag: $45.0M (2026-03-16) 路 Latest: $106.0M (2026-10-16)
| Window | CUE | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +155.3% | +6.0% | +149.4% | 2026-04-15 |
| 90 days | +203.2% | +14.3% | +188.9% | 2026-06-15 |
| 180 days | +259.0% | +15.5% | +243.5% | 2026-09-14 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider bought $100K (5 purchases)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | Sarraf Pasha Director | Purchase | 4,229 | $0.31 | $1K | no | Form 4 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | 77,148 | $0.30 | $23K | no | Form 4 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | 86,947 | $0.32 | $28K | no | Form 4 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | 78,116 | $0.31 | $24K | no | Form 4 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | 77,417 | $0.30 | $23K | no | Form 4 |
| 2026-03-16: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-12-16 to 2026-04-15. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"Risks Related to Our Business Our recurring losses from operations raise substantial doubt regarding our ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-K (period 2025-12-31)
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.